Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss and polycystic ovary syndrome are often linked.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Photobiomodulation may improve certain health conditions, but more high-quality research is needed.

Single-spin and double-spin PRP methods are equally effective for treating hair loss.

Oral minoxidil is a safe and effective treatment for alopecia, improving hair growth with minor side effects.

Wnt-activating drugs generally do not increase cancer risk.

Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.

Alkaloids help fight influenza in animals but need more research for human use.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Spironolactone effectively treats female acne with few side effects.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Finasteride is more harmful to male reproductive health than minoxidil.

Using minoxidil with microneedling increases hair count for hair loss without serious side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

PRP injections may help increase hair density in women with hair loss, but more research is needed.

PRP is an effective and safe treatment for hair loss.

Spironolactone can effectively treat hair loss with manageable side effects.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Familial dyskeratotic comedones are a rare, benign skin disorder that is hard to treat.

The RHD4 gene is crucial for consistent root hair growth in Arabidopsis thaliana.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.